Cargando…
Preclinical testing of dabigatran in trypsin-dependent pancreatitis
Pancreatitis, the inflammatory disorder of the pancreas, has no specific therapy. Genetic, biochemical, and animal model studies revealed that trypsin plays a central role in the onset and progression of pancreatitis. Here, we performed biochemical and preclinical mouse experiments to offer proof of...
Autores principales: | Pesei, Zsófia Gabriella, Jancsó, Zsanett, Demcsák, Alexandra, Németh, Balázs Csaba, Vajda, Sandor, Sahin-Tóth, Miklós |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675574/ https://www.ncbi.nlm.nih.gov/pubmed/36136430 http://dx.doi.org/10.1172/jci.insight.161145 |
Ejemplares similares
-
Misfolding-induced chronic pancreatitis in CPA1 N256K mutant mice is unaffected by global deletion of Ddit3/Chop
por: Németh, Balázs Csaba, et al.
Publicado: (2022) -
The common truncation variant in pancreatic lipase related protein 2 (PNLIPRP2) is expressed poorly and does not alter risk for chronic pancreatitis
por: Németh, Balázs Csaba, et al.
Publicado: (2018) -
Novel p.G250A Mutation Associated with Chronic Pancreatitis Highlights Misfolding-Prone Region in Carboxypeptidase A1 (CPA1)
por: Sándor, Máté, et al.
Publicado: (2022) -
Defective binding of SPINK1 variants is an uncommon mechanism for impaired trypsin inhibition in chronic pancreatitis
por: Szabó, András, et al.
Publicado: (2021) -
Genetic Risk in Chronic Pancreatitis: The Trypsin-Dependent Pathway
por: Hegyi, Eszter, et al.
Publicado: (2017)